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Background: The enzymatic activities of ATP10 
family of mammalian P4-ATPases are unknown. 
Results: ATP10A catalyzes flipping of NBD-PC. 
Expression of ATP10A altered cell shape, and 
inhibited cell adhesion and spreading. 
Conclusions: The enhanced PC-flipping activity 
by ATP10A changes the lipid composition which 
may cause a delay in cell spreading. 
Significance: This is the first evidence showing 
that PC-flipping activity by P4-ATPase is 
associated with the plasma membrane dynamics. 
 
Abstract 
We showed previously that ATP11A and 
ATP11C have flippase activity toward 
aminophospholipids (phosphatidylserine [PS] 
and phosphatidylethanolamine [PE]), and 
ATP8B1 and ATP8B2 have flippase activity 
toward phosphatidylcholine (PC). Here, we show 
that localization of class 5 P4-ATPases to the 
plasma membrane (ATP10A, ATP10D) and late 
endosomes (ATP10B) requires an interaction 
with CDC50A. Moreover, exogenous expression 
of ATP10A, but not its ATPase-deficient mutant, 
ATP10A(E203Q), dramatically increased PC 
flipping, but not flipping of PS or PE. Depletion 
of CDC50A made ATP10A retained at the ER 
instead of delivered to the plasma membrane, and 
abrogated the increased PC-flipping activity 
observed by expression of ATP10A. These results 
demonstrate that ATP10A is delivered to the 
plasma membrane via its interaction with 
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CDC50A, and specifically flips PC at the plasma 
membrane. Importantly, expression of ATP10A, 
but not ATP10A(E203Q), dramatically altered 
cell shape and decreased cell size. In addition, 
expression of ATP10A, but not ATP10A(E203Q), 
delayed cell adhesion and cell spreading onto the 
extracellular matrix. These results suggest that 
enhanced PC-flipping activity due to exogenous 
ATP10A expression alters the lipid composition 
at the plasma membrane, which may in turn cause 




In eukaryotic cells, the lipid bilayer of the 
plasma membrane and organelle membranes 
exhibits asymmetric lipid distributions (1-3). For 
example, in human erythrocytes, 
phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) are restricted 
primarily to the inner leaflet of the plasma 
membrane, whereas phosphatidylcholine (PC) 
and sphingomyelin (SM) are exposed on the cell 
surface (4,5).  
An ATP-dependent aminophospholipid 
translocase activity was discovered in the plasma 
membrane of human erythrocytes by Seigneuret 
and Devaux (6). Subsequently, P4-ATPases were 
identified as flippases in eukaryotic membranes 
(7-11). The yeast P4-ATPases (phospholipid 
flippases), Drs2p and Dnf1p/Dnf2p, flip PS and 
PC/PE, respectively (9,12). Mammals express 14 
P4-ATPases; class 1 (ATP8A1, ATP8A2, 
ATP8B1, ATP8B2, ATP8B3, and ATP8B4), class 
2 (ATP9A, and ATP9B), class 5 (ATP10A, 
ATP10B, and ATP10D), and class 6 (ATP11A, 
ATP11B, and ATP11C). These P4-ATPases form 
heteromeric complexes with members of the 
CDC50 family (10,13). We and others showed 
that most of the 14 mammalian P4-ATPases, 
except for ATP9A and ATP9B, require 
association with CDC50 for their exit from the 
endoplasmic reticulum (ER) and subsequent 
subcellular localization (14-18). Moreover, we 
recently showed that ATP11A and ATP11C can 
flip NBD-labeled aminophospholipids, NBD-PS 
and -PE, and that ATP8B1 and ATP8B2 
preferentially flip NBD-PC at the plasma 
membrane (19). 
The phospholipid asymmetry regulated by 
P4-ATPases is indispensable for the homeostasis 
of multicellular organisms. Loss of phospholipid 
asymmetry due to mutations in the human 
FIC1/ATP8B1 (a member of the P4-ATPase 
family) gene causes progressive familial 
intrahepatic cholestasis (PFIC) (20,21). We 
showed that some ATP8B1 mutants found in type 
1 PFIC fail to flip PC, indicating that PC-flipping 
activity at the bile canaliculi is critical for proper 
bile excretion in liver (19). ATP8A1 deficiency 
causes surface externalization of PS in the 
hippocampus and delays hippocampus-dependent 
learning (22). ATP11C deficiency causes a defect 
in B-cell maturation, altered erythrocyte shape, 
and anemia (23,24). During apoptosis, ATP11C 
undergoes caspase-mediated cleavage and is 
consequently inactivated, resulting in PS 
exposure on the cell surface (25). Heterozygous 
deletion of ATP10A in mice causes diet-induced 
obesity, type 2 diabetes, and nonalcoholic fatty 
liver disease, implicating ATP10A in obesity-
related metabolic abnormalities (26). ATP10A is 
3 
 
also implicated in regulation of insulin-stimulated 
glucose uptake (27,28). However, the flippase 
activity and substrate specificities of ATP10A 
remain to be determined.  
In this study, we characterized the 
interaction of the class 5 P4-ATPases (ATP10A, 
ATP10B, and ATP10D) with CDC50 proteins and 
investigated their flippase activities. We found 
that class 5 P4-ATPases preferentially interact 
with CDC50A. Importantly, plasma membrane–
localized ATP10A exhibited flippase activity 
toward NBD-PC. Moreover, elevated PC-flipping 
activity due to exogenous ATP10A expression 
caused changes in cell shape and cell size, and 
inhibited cell adhesion and spreading onto the 
extracellular matrix.  
 
Experimental procedures 
RT-PCR —Total RNA from HeLa 
cells was isolated using the RNeasy Mini kit 
(Qiagen) or Isogen (Nippon Gene), and then 
subjected to RT-PCR analysis using the 
SuperScript III One-Step RT-PCR system 
(Invitrogen). The CDC50A cDNA was amplified 
using the following primer pair: sense, 
GAAAAAGAAAGGTATTGCTTGGTG; anti-
sense, GTAATGTCAGCTGTATTACTACTG.  
Plasmids — Expression vectors for C-
terminally HA-tagged P4-ATPases and N-
terminally FLAG-tagged CDC50A or CDC50B 
were constructed as described previously (18). 
ABCB4 cDNA was a kind gift from Kazumitsu 
Ueda (Kyoto University). The pCAG-based 
vector for expression of ABCB4 with a C-
terminal HA tag was constructed. ABCB4 cDNA 
was cloned into the pENTR3C vector 
(Invitrogen), and the pCAG-HA–based vector 
was prepared as described previously (18). 
Transfer of the ABCB4 cDNA to expression 
vectors was performed using the Gateway system 
(Invitrogen). 
Antibodies and reagents — The 
sources of antibodies used in the present study 
were as follows: monoclonal mouse anti-TfnR 
(H68.4), Zymed; monoclonal mouse anti-
calnexin, anti-EEA1 and anti-Lamp-1, BD 
Biosciences; monoclonal rat anti-HA (3F10), 
Roche Applied Science; polyclonal rabbit anti-
FLAG, Sigma-Aldrich; monoclonal mouse anti-
DYKDDDK (1E6), Wako; mouse anti--tubulin, 
Millipore; Alexa Fluor 488-conjugated 
monoclonal mouse anti-CD147 (HIM6), 
BioLegend; Alexa Fluor–conjugated secondary 
antibodies, Molecular Probes; Cy3-conjugated 
and horseradish peroxidase-conjugated 
secondary antibodies, Jackson ImmunoResearch 
Laboratories. For monoclonal mouse antibody to 
MHCI, a hybridoma clone (W6/32) was 
purchased from ATCC. Alexa Fluor 488–
conjugated Phalloidin was purchased from 
Molecular Probes. Fibronectin was purchased 
from Sigma. The NBD-labeled phospholipids 














Cell Culture, siRNA-mediated 
knockdown, and immunofluorescence analysis 
— HeLa cells were maintained in Minimum 
Essential Medium Eagle (MEM) (Nacalai 
Tesque) supplemented with 5% or 10% heat-
inactivated fetal bovine serum (Invitrogen) and 
non-essential amino acids (Nacalai Tesque). 
Preparation of pools of siRNAs for CDC50A and 
ATP10A, and knockdowns using these siRNA 
pools, were performed as described previously 
(18,29). Briefly, a pool of siRNAs directed 
against nucleotides 5971086 of the CDC50A 
mRNA or nucleotides 6551399 of the ATP10A 
mRNA (the A residue of the initiation Met codon 
was defined as nucleotide 1) was prepared using 
the BLOCK-iT RNAi TOPO transcription kit and 
BLOCK-iT Dicer RNAi kit (Invitrogen). HeLa 
cells were transfected with the siRNA pool using 
Lipofectamine 2000 (Invitrogen) and incubated 
for 24 h. The transfected cells were then 
transferred to a culture dish containing coverslips, 
incubated for an additional 48 h, and processed 
for immunoblotting, immunofluorescence, and 
RT-PCR analyses.  
For retroviral production, pMXs-neo–
derived vectors for expression of HA-tagged P4-
ATPases were co-transfected with pEF-gag-pol 
and pCMV-VSVG-Rsv-Rev into HEK293T cells 
as described previously (18). The resultant 
retroviruses were concentrated and then used to 
infect HeLa cells to establish stable cell lines. The 
infected cells were selected in medium containing 
G418 (1 mg/ml). To transiently express P4-
ATPases, HeLa cells were transfected with a 
pCAG-HA–based vector carrying P4-ATPase 
cDNA and a pcDNA3-FLAG–based vector 
carrying CDC50A cDNA (18) using X-
tremeGENE9 (Roche Applied Science) or 
polyethyleneimine (Sigma). Two days later, the 
transfected cells were fixed for 
immunofluorescence or lysed for immunoblotting 
analysis.  
Immunofluorescence staining was 
performed as described previously (30,31) and 
visualized, using an Axiovert 200MAT 
microscope (Carl Zeiss, Thornwood, NY). For 
the plasma membrane staining, cells were 
incubated with Alexa Fluor 488-conjugated anti-
CD147 or anti-MHCI antibody for 10 min at 
room temperature prior to permeabilization, fixed 
and processed for immunofluorescence analysis. 
To obtain quantitative data of cell areas, the 
surface areas of cells were stained with anti-
MHCI antibody and CDC50A or P4-ATPases 
expressing cells were chosen. The areas of the 
cells were measured with the ImageJ software.  
Flippase assay — Incorporation of 
NBD-phospholipids was analyzed by flow 
cytometry, as described previously (19). HeLa 
cells were detached from dishes in PBS 
containing 5 mM EDTA, and then harvested by 
centrifugation. The cells (1 × 106 cells per 
sample) were washed and equilibrated at 15°C for 
15 min in 500 l of Hank’s balanced salt solution 
(pH 7.4) containing 1 g/L glucose (HBSS-
glucose). An equal volume of 2 M NBD-
phospholipid in HBSS-glucose was added to the 
cell suspension and incubated at 15°C. At each 
time point, 200 L of cell suspension was 
collected and mixed with 200 L of ice-cold 
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HBSS-glucose containing 5% fatty acid–free 
BSA (Wako Pure Chemicals) in order to extract 
NBD-lipids incorporated into the exoplasmic 
leaflet of the plasma membrane, as well as 
unincorporated ones. Next, 5,000 or 10,000 cells 
were analyzed with a FACSCalibur (BD 
Biosciences) to measure fluorescence of NBD-
lipids translocated into the cytoplasmic leaflet of 
the plasma membrane, and mean fluorescence 
intensity per cell was calculated. Propidium 
iodide–positive cells (i.e., dead cells) were 
excluded from the analysis. 
Immunoprecipitation — HeLa cells 
were transfected using polyethyleneimine with 
different combinations of expression vectors for 
P4-ATPase and CDC50, and grown for two days. 
The cells were then lysed in lysis buffer (20 mM 
HEPES [pH 7.4], 150 mM NaCl, 1mM EDTA, 
1% NP-40) containing a Protease Inhibitor 
Cocktail (Nacalai Tesque) at 4°C for 30 min. The 
lysates were centrifuged at maximum speed for 
20 min at 4°C in a microcentrifuge to remove 
cellular debris and insoluble materials. The 
supernatant was incubated with an anti-HA 
antibody at 4°C for 15 min and then incubated 
with Protein Gcoupled Dynabeads (Invitrogen) 
at 4°C overnight. After washing, beads were 
incubated in SDS sample buffer including -
mercaptoethanol at 37°C for 2 h, and the 
supernatant was subjected to SDS-PAGE and 
immunoblot analysis using rat anti-HA, mouse 
anti-DYKDDDK, or mouse anti--tubulin 
antibody. Immunoblots were developed using a 
Chemi-Lumi One L or Chemi-Lumi One Super 
kit (Nacalai Tesque), recorded on a LAS-3000 
bioimaging system (Fujifilm) and quantified 
using Image Gauge software (Version 4.0, 
Fujifilm). 
For crosslinker treatment, 10 mM DSP 
(dithiobis[succinimidylpropionate]) (Thermo 
Scientific) was freshly prepared by dissolving in 
DMSO. Transfected cells were washed twice with 
PBS++ (including 0.1 mM CaCl2 and 0.1 mM 
MgCl2) and treated with 1 mM DSP in PBS++ for 
30 min at room temperature. In order to stop the 
reaction, 1 M Tris (pH 7.5) was added at a final 
concentration of 20 mM and incubated for 15 min 
at room temperature. The cells were washed with 
PBS(-), lysed, and immunoprecipitated as 
described above. 
Cell adhesion and spreading assay — 
HeLa cells were detached from dishes in PBS 
containing 5 mM EDTA, and harvested by 
centrifugation. The cells were washed and 
resuspended in complete growth medium, plated 
onto 24-well plates (1 × 105 cells per well), and 
incubated at 37°C in 5% CO2 for the indicated 
times. The same number of cells was removed, 
and DNA content was measured using a Qubit 
fluorometer (Life Technologies). After 
incubation at 37°C, the cells were fixed with 96% 
of ethanol and stained with 1% crystal violet in 
10% ethanol at room temperature. After washing 
the cells with PBS, the stain was extracted using 
1% Triton X-100 and processed for measurement 
of absorbance at 570 nm. Absorbance was 
normalized to the ratio of DNA content. 
For the cell spreading assay, cells were 
harvested as described above, washed with 
serum-free MEM, and seeded onto fibronectin- or 
FBS-coated coverslips. After incubation at 37°C 
in 5% CO2 for indicated times, cells were fixed 
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with 3% PFA and subjected to 
immunofluorescence analysis. AlexaFluor 488–
conjugated phalloidin was added during 
incubation with secondary antibody. 
Immunofluorescence staining was performed as 
described previously (30,31) and observed using 
an Axiovert 200MAT microscope (Carl Zeiss, 
Thornwood, NY, USA). To obtain quantitative 
data of the extent of cell spreading, cells were 
stained with phalloidin and randomly chosen 
fields were acquired. Cell areas were measured 






CDC50-dependent subcellular localization of 
ATP10A, ATP10B, and ATP10D  
Previously, we demonstrated that CDC50 is 
required for proper subcellular localization of 
human P4-ATPases, and performed an co-
immunoprecipitation analysis that elucidated its 
physical interactions with P4-ATPases (18), with 
the exception of the class 5 P4-ATPases (ATP10A, 
ATP10B, and ATP10D). In this study, we 
transiently expressed C-terminally HA-tagged 
class 5 P4-ATPases in HeLa cells, either alone or 
in combination with N-terminally FLAG-tagged 
CDC50A or CDC50B (Figure 1, A–C), and 
observed their localization (Figure 1; insets show 
CDC50 expression). In the absence of exogenous 
CDC50 expression or in the presence of 
exogenous CDC50B, all three class 5 P4-ATPases 
were predominantly localized to the ER, as 
demonstrated by their almost complete overlap 
with an ER marker protein, calnexin (Figure 1, 
A–C, a–a’’, and c–c’’). By contrast, in the 
presence of exogenous CDC50A, ATP10A and 
ATP10D were localized primarily on the plasma 
membrane (Figure 1, Ab and Cb), and ATP10B 
was localized on punctate structures in the 
cytoplasm (Figure 1Bb), as described previously 
(18). The perinuclear staining of ATP10A, 
ATP10B, and ATP10D might reflect protein en 
route to the plasma membrane during 
biosynthetic pathway. Next we compared the 
subcellular localization of these ATPases with 
organelle marker proteins (Figure 1, D and E). 
ATP10A and ATP10D were extensively 
colocalized with a plasma membrane marker, 
CD147 (Figure 1D). On the other hand, the 
punctate ATP10B staining overlapped with that of 
a late endosomal/lysosomal marker, Lamp-1 
(Figure 1E), but only rarely with an early 
endosomal marker, EEA1, or an early/recycling 
endosomal marker, transferrin receptor (TfnR), 
indicating that ATP10B is mainly localized to late 
endosomes and lysosomes. In the presence of 
CDC50A, ATPase-deficient glutamate-to-
glutamine mutants (19,32) of ATP10A and 
ATP10D were colocalized with markers for the 
plasma membrane, whereas an analogous mutant 
of ATP10B was localized to 
endosomes/lysosomes, (Figure 1F), indicating 
that ATPase activity may not be a prerequisite for 
their exit from the ER or delivery to their final 
destinations. Notably, expression of ATP10A, but 
not ATP10A(E203Q), caused significant changes 
in cell shape (Figure 1, Ab, D, and F); we discuss 
the physiological relevance of this observation 
below. 
 
Association of ATP10A, ATP10B, and ATP10D 
with CDC50A 
We next investigated whether ATP10A, 
ATP10B, and ATP10D physically interact with 
CDC50A. To this end, we transiently transfected 
HeLa cells with expression vectors for C-
terminally HA-tagged P4-ATPase and FLAG-
CDC50A, prepared total lysates from the 
transfected cells, immunoprecipitated the lysates 
with anti-HA antibody, and subjected the 
immunoprecipitates to immunoblotting with anti-
HA or anti-FLAG antibody (Figure 2). 
Expression of the tagged proteins was confirmed 
by immunoblotting of total cell lysates (Figure 2, 
input panels). As shown in the bottom two panels 
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in Figure 2A, ATP10A-HA co-
immunoprecipitated FLAG-CDC50A (lane 3), 
but much less efficiently than ATP8B1 and 
ATP11A (lanes 6 and 7); FLAG-CDC50A 
migrated as a smear in the SDS-polyacrylamide 
gel, probably due to heterogeneous glycosylation 
(18). To our surprise, however, FLAG-CDC50A 
was not co-immunoprecipitated when 
coexpressed with ATP10B-HA or ATP10D-HA 
(lanes 4 and 5). These results suggest that 
interaction of the ATP10 proteins with CDC50A 
might be transient or much weaker than those of 
other P4-ATPases. To overcome this problem, we 
performed co-immunoprecipitation after treating 
the cells with a thiol-cleavable cross-linker, 
dithiobis(succinimidylpropionate) (DSP) (Figure 
2B). The transfected cells were treated with DSP; 
after quenching, they were lysed, 
immunoprecipitated with anti-HA antibody, and 
subjected to SDS-PAGE under reducing 
conditions followed by immunoblotting with 
anti-HA or anti-FLAG antibody (Figure 2B). By 
the DSP treatment, CDC50A was co-
immunoprecipitated with ATP10B and ATP10D 
(Figure 2, B, lanes 12 and 13), as well as with 
ATP10A (lane 11). The amount of CDC50A that 
co-immunoprecipitated with ATP10D increased 
dramatically in the presence of DSP (compare 
lane 5 with lane 13), and the amount that co-
immunoprecipitated with ATP10A or ATP10B 
increased slightly (compare lane 3 with lane 11, 
or lane 4 with lane 12, respectively). Thus, the 
interaction between CDC50A and ATP10 
proteins, especially ATP10B and ATP10D, may 
not be as stable as the interaction between 
CDC50A and other P4-ATPases, such as ATP8B1 
and ATP11A. Because non-specific bands can be 
detected in the presence of DSP (lanes 9 and 10), 
we made use of a transmembrane protein, 
ABCB4, an ABC transporter that localizes to the 
plasma membrane (33), as a negative control 
(lane 16) and quantified the band intensities 
(Figure 2B, bottom panel). Taken together, these 
data indicate that CDC50A physically interacts 
with ATP10 proteins, but with lower affinity than 
with other P4-ATPases, and is required for exit 
from the ER followed by localization to their 
destinations.  
 
ATP10A translocates NBD-PC 
In a recent study, we elucidated the flippase 
activities and substrate specificities of plasma 
membrane-localizing P4-ATPases, ATP8B1, 
ATP8B2, ATP11A, and ATP11C, using NBD-
labeled phospholipids (19); ATP11A translocates 
aminophospholipids (PS and PE) (Figure 3, B and 
C), whereas ATP8B1 preferentially flips PC 
(Figure 3A) (19). Here, we investigated the 
flippase activities of ATP10A and ATP10D, 
which are also localized to the plasma membrane 
(see Figure 1). To this end, we first established 
cells stably expressing ATP10A, 
ATP10A(E203Q), or ATP10D by infection with 
recombinant retrovirus. Although exogenous 
expression of CDC50A is required for proper 
localization of the transiently expressed ATP10 
protein (see Figure 1), stably expressed ATP10A 
and ATP10D were detected at the plasma 
membrane in the absence of exogenous CDC50A 
expression (see Figure 5, A, a, a’, b, b’, e, and e’). 
As described previously (19), this probably 
reflects the fact that the endogenous level of 
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CDC50A is sufficient for localization of ATP10A 
and ATP10D expressed at moderate levels in 
stable cells. Intriguingly, cells stably expressing 
ATP10A exhibited a high selective flippase 
activity toward NBD-PC (Figure 3, A and E), but 
not toward any other NBD-lipids that we 
examined (Figure 3, B–D and F–H). Furthermore, 
the PC-flipping activity of ATP10A-expressing 
cells was much higher than that of cells stably 
expressing ATP8B1 (Figure 3A). By contrast, 
cells stably expressing ATP10A(E203Q), an 
ATPase-deficient mutant, did not exhibit 
significant flippase activity toward NBD-PC 
(Figure 3A) although the expression level of 
ATP10A(E203Q) was comparable to that of 
ATP10A (Figure 3I), indicating that the increase 
in translocation of NBD-PC from the exoplasmic 
to the cytoplasmic leaflet in ATP10A-expressing 
cells was dependent on the ATPase cycle of 
ATP10A.  
We also examined the time course of 
flippase activities in ATP10A-expressing cells 
(Figure 3, E–H). HeLa cells stably expressing 
ATP10A exhibited a more dramatic increase in 
the amount of BSA–non-extractable NBD-PC 
than control HeLa cells (Figure 3E). By contrast, 
the time-dependent increase in the amount of 
NBD-PS, NBD-PE, or NBD-SM in ATP10A-
expressing cells did not differ significantly from 
that in control cells (Figure 3, F–H). We did not 
detect flippase activity of ATP10D toward any of 
the NBD-lipids we examined. ATP10D might 
have flippase activity toward other lipids, 
although we cannot exclude a possibility that the 
flippase activity of ATP10D was undetectable due 
to its low specific activity and/or low expression 
level in the stable cells (Figure 3I).  
In order to confirm that the PC-flipping 
activity observed in the ATP10A-expressing cells 
was indeed due to ATP10A expression, we treated 
cells stably expressing ATP10A or 
ATP10A(E203Q) with siRNAs targeting ATP10A 
and examined their flippase activities. 
Immunoblot analysis revealed that the expression 
level of ATP10A or ATP10A(E203Q) was 
significantly reduced in knockdown cells (Figure 
3J). In parallel with the decrease in ATP10A 
expression levels, the flipping activity toward 
NBD-PC was dramatically decreased by 
treatment with ATP10A siRNA, but not control 
siRNAs (siRNAs for LacZ) (Figure 3K), 
indicating that the observed PC-flipping activity 
could be attributed to ATP10A expression. By 
contrast, ATP10A depletion did not affect the 
uptake of other NBD-lipids (Figure 3, L–N). 
Notably, depletion of ATP10A in control HeLa 
cells did not decrease basal PC-flipping activity 
(Figure 3K, open and closed bars in vector). 
 
Coexpression of CDC50A, but not CDC50B, 
with ATP10A or ATP11A increases the 
phospholipid flipping activities 
Here and in our previous study, we showed 
that ATP10A, ATP8B1, and ATP11A are 
localized to the plasma membrane in a CDC50A-
dependent manner. Therefore, we asked whether 
the phospholipid flipping activities of ATP10A, 
ATP8B1, and ATP11A are dependent on 
CDC50A as well. To this end, we transiently 
coexpressed ATP10A, ATP8B1, and ATP11A 
with either CDC50A or CDC50B in HeLa cells 
and subjected the cells to the flippase assay. 
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Exogenous expression of ATP10A alone 
moderately increased flippase activity toward 
NBD-PC, relative to vector-transfected control 
cells (Figure 4A, gray bars), suggesting that some 
ATP10A might be transported to the plasma 
membrane by endogenous CDC50A. 
Coexpression of CDC50A with ATP10A further 
increased the PC-flipping activity (Figure 4A, 
closed bars). By contrast, cells coexpressing 
CDC50B with ATP10A (Figure 4A, open bar) 
exhibited a PC-flipping activity comparable to 
those expressing ATP10A alone (gray bar). 
Coexpression of ATP11A with CDC50A, but not 
CDC50B, increases flipping activity toward 
NBD-PS and NBD-PE (Figure 4, B and C). These 
results are consistent with Figs. 1 and 2, showing 
that ATP10A and ATP11A are delivered to the 
plasma membrane in a CDC50A-dependent 
manner, and are thus able to exert flipping activity. 
Expression of ATP8B1 tended to increase PC-
flipping activity, although the effect was not 
statistically significant (Figure 4A, gray bar), and 
coexpression of ATP8B1 with CDC50A slightly 
but significantly increased the activity (Figure 4A, 
black bar). The activity of ATP8B1 might be 
difficult to detect in transiently expressing cells, 
because the PC-flipping activity of ATP8B1 was 
much lower than that of ATP10A even in stably 
expressing cells (Figure 3A).  
 
CDC50A knockdown induces mislocalization 
of ATP10A, ATP10D, ATP8B1, and ATP11A 
and abolishes flippase activities 
We next examined whether endogenous 
CDC50A is critical for plasma membrane 
localization and flippase activities of ATP10A, 
ATP10D, ATP8B1, and ATP11A. To this end, we 
knocked down endogenous CDC50A by RNAi in 
cells stably expressing ATP10A, ATP10D, 
ATP8B1 or ATP11A, and then examined whether 
CDC50A depletion affected their localization and 
flippase activities. Because no antibody against 
CDC50A was available, we confirmed specific 
and efficient knockdown of CDC50A by RT-PCR 
(Figure 5F). As shown in Figure 5A, CDC50A 
depletion caused mislocalization of ATP10A, 
ATP10D, ATP8B1, and ATP11A to the ER, 
overlapping with calnexin (d, d’, g, g’, j, j’, m, 
and m’). These observations strongly support the 
idea that endogenous CDC50A is primarily 
required for the ER exit and plasma membrane 
localization of ATP10A, ATP10D, ATP8B1, and 
ATP11A. 
We next asked whether the flippase activities 
of cells stably expressing ATP10A, ATP8B1, or 
ATP11A were affected by the CDC50A depletion. 
CDC50A depletion reversed the PC-flipping 
activities observed in cells stably expressing 
ATP10A or ATP8B1 (Figure 5B) and decreased 
the PS- and PE-flipping activities observed in 
ATP11A-expressing cells (Figure 5, C and D). 
These data indicate that these P4-ATPases cannot 
be transported to the plasma membrane in the 
absence of CDC50A, abrogating the 
phospholipid-flipping activities observed in cells 
stably expressing the P4-ATPases.  
Notably, in vector-infected control HeLa cells, 
depletion of CDC50A markedly decreased PS- 
and PE-flipping activities, but barely decreased 
PC-flipping activity (Figure 5, B, C, and D, open 
bars in vector). The dramatic decrease in PS-
flipping activities in cells depleted of CDC50A 
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might be ascribed to failed delivery of 
endogenous PS-flipping P4-ATPases to the 
plasma membrane in the absence of CDC50A. 
These data are compatible with the fact that 
endogenous PS-flipping activity in HeLa cells is 
much higher than the activities toward other 
phospholipids (compare Figure 3, E–H; also see 
(19)). Therefore, the high and constitutive PS-
flipping activities might be required in HeLa cells 
to prevent the exposure of PS to the outer leaflet 
and to maintain the asymmetry between the two 
leaflets of the plasma membrane. On the other 
hand, the PC-flipping event might occur at a very 
low rate at steady state, or might be required 
under specific conditions (such as in response to 
signals) or in a specific place (such as the bile 
canaliculi) (19,20,34). 
 
Enhanced PC-flipping activity alters cell shape 
and decreases cell size 
   During the course of our experiments, we 
noticed that cell shape was significantly altered 
by overexpression of ATP10A, but not the 
ATP10A(E203Q) mutant (Figures. 1, Ab, D, and 
F, and 6). As shown in Figure 6A, the shape of 
cells transiently expressing ATP10A(WT) and 
CDC50A (Ac) was dramatically altered relative 
to that of control cells (Aa). By contrast, cells 
transiently expressing CDC50A alone (Ab) or 
those expressing ATP10A(E203Q) and CDC50A 
(Ad) did not exhibit an observable shape change 
relative to control cells (Aa). To quantitatively 
show the change in cell shape, we stained the cells 
with a plasma membrane marker, MHCI, and 
quantitated cell areas using the ImageJ software 
(Figure 6, A and B). The frequency distribution of 
cell areas revealed that the population of small-
sized cells markedly increased upon co-
expression of ATP10A and CDC50A (Figure 
6Bc). By contrast, the frequency distribution of 
cell areas in cells co-expressing ATP10A(E203Q) 
and CDC50A (Bd) was not significantly changed 
relative to control (Ba) or CDC50A-expressing 
cells (Bb). These results indicate that the change 
in cell shape and decrease in cell size could be 
ascribed to enhanced PC-flipping activity due to 
elevated expression of ATP10A at the plasma 
membrane.  
 
Enhanced PC-flipping activity inhibits cell 
adhesion and spreading. 
   We next asked whether cell adhesion and 
spreading were altered by ATP10A expression. 
For this purpose, we examined the efficiency of 
cell adhesion in cells stably expressing ATP10A 
and ATP10A(E203Q). Cells detached from the 
dishes by treatment with EDTA were resuspended 
with medium supplemented with FBS and seeded 
onto plastic dishes. After incubation for the 
indicated times, non-adherent cells were removed 
by washing with PBS, and adherent cells were 
stained with crystal violet. The stain was then 
extracted from cells and quantitated by measuring 
the absorbance at 570 nm; although the same 
numbers of cells were seeded, the absorbance was 
normalized to the DNA content of the seeded cells 
to achieve a more accurate assessment. As shown 
in Figure 7A and B, adhesion of ATP10A-
expressing cells was delayed relative to the 
control cells; by contrast, adhesion of 
ATP10A(E203Q)-expressing cells was not 
delayed, but instead slightly accelerated. After 60 
12 
 
min incubation, cell adhesion was comparable 
among cells expressing ATP10A or 
ATP10A(E203Q) and control cells (Figure 7A). 
Thus, cell adhesion was delayed in cells 
expressing ATP10A(WT). Notably, the extent of 
cell spreading at the 60 min time point appeared 
to be lower in cells expressing ATP10A(WT) 
(Figure 7B, middle panel) relative to control and 
ATP10A(E203Q)-expressing cells (Figure 7B, 
top and bottom panels, respectively). Therefore, 
we next asked whether cell spreading was 
affected by expression of ATP10A. To this end, 
cells stably expressing ATP10A(WT) or 
ATP10A(E203Q) were detached from dishes by 
EDTA treatment, resuspended in serum-free 
medium, and seeded onto FBS- or fibronectin-
coated coverslips. As shown in Figure 7C and E, 
cells stably expressing ATP10A spread more 
slowly onto the FBS- or fibronectin-coated 
coverslips than control cells and those expressing 
ATP10A(E203Q) (compare the cells at 60, 120, 
and 180 min time points). We quantitated the 
areas of the cells at the 180 min time point by the 
MetaMorph software (Figure 7, D and F). The 
frequency distribution of cell areas revealed that 
the population of small-sized cells significantly 
increased upon stable expression of 
ATP10A(WT), but not ATP10A(E203Q) (Figure 
7, D and F). Taken together, these observations 
indicate that the suppression of cell adhesion and 
cell spreading observed in cells expressing 





In this study, we demonstrated that class 5 P4-
ATPases (ATP10A, ATP10B, and ATP10D) 
require their interaction with CDC50A for their 
exit from the ER and localization to specific 
cellular compartments where they exert their 
functions (Figure 1). Importantly, we revealed 
that ATP10A has PC-specific flipping activity. 
Moreover, the enhanced PC-flipping activity 
resulting from expression of ATP10A leads to 
changes in cell shape and delays cell adhesion and 
spreading. 
Unlike ATP8B1 and ATP11A, members of 
the ATP10 family (especially ATP10B and 
ATP10D) associate with glycosylated CDC50A 
with low affinity (Figure 2). Even if the 
interaction between ATP10 proteins and 
CDC50A is not as strong as that between ATP8B1 
or ATP11A and CDC50A, the interaction is 
nonetheless critical for the localization of ATP10 
proteins to their final destinations: the plasma 
membrane for ATP10A and ATP10D, and late 
endosomes for ATP10B (Fig. 1). In support of this 
result, these P4-ATPases did not exit the ER in 
cells depleted of CDC50A (Figure 5A). By 
contrast, CDC50B was dispensable for exit of 
ATP10 proteins from the ER.  
Importantly, exogenous expression of 
ATP10A in HeLa cells dramatically increases 
NBD-PC-flipping activity, but not flipping of 
NBD-aminophospholipids (Figure 3). This 
activity was abolished by treatment with 
siCDC50A, confirming that CDC50A is critical 
for plasma-membrane localization of ATP10A 
(Figure 5). We did not detect any flippase activity 
of ATP10D toward PC, PS, PE, or SM. However, 
ATP10D may have activities toward other 
phospholipids that were not tested in this study, or 
exhibit activity in response to specific signaling 
events.  
In yeast, Dnf1p prefers PC and PE (9,35), 
whereas Drs2p prefers PS (11). Several key 
residues have been proposed to determine the 
phospholipid specificities of Drs2p and Dnf1p 
(36,37). We aligned and compared the primary 
sequences between PS- and PC-flipping P4-
ATPases of yeast and human (Figure 8) (19,38). 
Many of key residues required for PC-flipping 
activity of Dnf1p are not conserved in PC-
flipping human P4-ATPases (ATP10A, ATP8B1, 
and ATP8B2) except for the Ile located in the 
cytoplasmic region close to the TM3 (Figure 8B, 
bold blue letters and underlined bold letters). 
Some residues required for PS selectivity of 
Drs2p (bold red letters) (36) are not conserved in 
PS-flipping human P4-ATPases. Thus, the 
residues that contribute to PC and PS selectivity 
in yeast P4-ATPases do not always hold true for 
human P4-ATPases. On the other hand, some 
residues are conserved among mammalian PC-
specific P4-ATPases (Figure 8, bold light blue 
letters) and others are conserved among PS-
specific P4-ATPases (bold pink letters), raising an 
interesting question of whether these residues are 
critical for determining substrate specificities. 
The increase in PC-flipping activity resulting 
from ATP10A expression may alter plasma 
membrane dynamics, resulting in drastic changes 
in cell shape and a reduction in cell size. 
Moreover, cell adhesion and spreading onto the 
extracellular matrix were significantly delayed by 
ATP10A expression. By contrast, expression of 
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ATP10A(E203Q), an ATPase-deficient mutant, 
affected neither cell shape nor cell spreading, 
indicating that these phenotypic changes caused 
by ATP10A expression can be ascribed to 
enhanced PC-flipping activity at the plasma 
membrane. Although the exact molecular 
mechanism underlying the phenotypic changes 
induced by ATP10A expression remains to be 
addressed in future studies, we propose two 
hypotheses: 1) Because PC is the most abundant 
phospholipid in cellular membranes, enhanced 
translocation of PC from the extracellular to the 
cytoplasmic leaflet increases the PC ratio of the 
cytoplasmic leaflet to the extracellular leaflet, 
favoring positive curvature toward the cytoplasm. 
Therefore, outward growth of cells, such as cell 
spreading, might be inhibited, resulting in a 
reduction in cell size. Compatible with this 
possibility, a mutation in mouse ATP11C, which 
flips PS and PE at the plasma membrane, altered 
erythrocyte morphology (24). 2) The enhanced 
translocation of PC to the cytoplasmic leaflet may 
reduce the local concentration of PS or 
phosphatidylinositol 4,5-bisphosphate (PIP2) in 
the cytoplasmic leaflet. Because PS and PIP2 play 
critical roles in remodeling of the actin 
cytoskeleton for cell adhesion, spreading, and 
migration, a decrease in the local concentration of 
PS or PIP2 might inhibit cell adhesion and 
spreading. Indeed, in budding yeast, local 
concentration of PS is indispensable for 
recruitment of Cdc42 to polarized bud tips, and 
both PS concentration and Cdc42 recycling are 
regulated by flippase activity of Dnf1p/Dnf2p, 
which flips PE and PC (39,40).  
Genetic studies demonstrate that 
Dnf1p/Dnf2p translocate lyso-PE and lyso-PC 
into the inner/cytoplasmic leaflet of the plasma 
membrane, and they are in turn converted to PE 
and PC, respectively, by an acyltransferase. 
Therefore, lyso-PE and lyso-PC might be sources 
for synthesis of PE and PC in order to support the 
lipid content and membrane biogenesis in yeast 
(41). Hence, we cannot exclude the possibility 
that ATP10A might be able to transport lyso-PC. 
Depletion of CDC50A dramatically decreased 
the PS-flipping activity, but did not significantly 
decrease the PC-flipping activity in HeLa cells. 
Therefore, it is likely that the basal PC-flipping 
activity by endogenous P4-ATPases in HeLa cells 
is not as high as the PS-flipping activity, which is 
indispensable for preventing unnecessary 
exposure of PS to the exoplasmic leaflet of the 
plasma membrane. A recent study showed that 
knockout of CDC50A in KBM-7 cells 
dramatically decreases flipping activity toward 
PC as well as PS (25). In addition, the PC-flipping 
activity of ATP8B1 is required for proper bile 
excretion in the liver (19,34,42). Therefore, the 
level of basal PC-flipping activity might vary in 
different cell types and tissues, raising questions 
about the regulation of PC-flipping activity. In 
budding yeast, the P4-ATPases (preferentially 
Dnf1p and Dnf2p) require phosphorylation by 
Fpk1 for their functions (43), and Drs2p requires 
an interaction with phosphatidylinositol 4-
phosphate for its activity (44). It is tempting to 
speculate that PC-flipping P4-ATPases might be 
regulated by phosphorylation in response to 
specific cellular signaling events, or by their 
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Figure 1. Changes in localization of transiently expressed P4-ATPases upon co-expression of 
CDC50  
HeLa cells were transiently co-transfected with an expression vector for C-terminally HA-tagged P4-
ATPase and a control pcDNA3 vector (AC, aa’’) or an expression vector for N-terminally FLAG-
tagged CDC50A (AC, bb’’, D, and E) or CDC50B (AC, cc’’). In (F), HeLa cells were transiently 
co-transfected with an expression vector for a glutamate mutant of P4-ATPase with a C-terminal HA 
tag and FLAG-CDC50A. After 48 h of transfection, the cells were fixed and processed for 
immunofluorescence microscopy. (AC) Cells were stained with anti-HA, anti-FLAG, and anti-
calnexin antibodies followed by Cy3-conjugated anti-rat, Alexa Flour 647-conjugated anti-rabbit, and 
Alexa Fluor 488–conjugated anti-mouse antibodies. (D and F). For plasma membrane staining, cells 
were incubated with Alexa Fluor 488–conjugated anti-CD147 antibody to label the surface prior to 
permeabilization. After permeabilization, cells were incubated with anti-HA and anti-FLAG antibodies 
followed by Cy3-conjugated anti-rat and Alexa Flour 647-conjugated anti-rabbit antibodies. (E and F) 
Cells were fixed and stained with antibodies against HA or FLAG and Lamp-1, EEA1, or TfnR (as 
indicated), followed by Cy3-conjugated anti-rat, Alexa Flour 647-conjugated anti-rabbit, and Alexa 
Fluor 488–conjugated anti-mouse antibodies. Insets show cells expressing FLAG-tagged CDC50A or 
CDC50B. Bars, 20 m. Bars in enlarged images, 10 m.  
 
Figure 2. Co-immunoprecipitation analysis of interactions between P4-ATPases and CDC50 
proteins 
HeLa cells were transfected with an expression vector for FLAG-CDC50A, either alone (lanes 2 and 
10) or in combination with an expression vector for HA-tagged P4-ATPase or HA-tagged ABCB4 (lanes 
8 and 16). In mock lanes (lanes 1 and 9), HeLa cells were transfected with an empty vector in the 
absence (A) or presence (B) of crosslinker, DSP, as indicated. After 48 h of transfection, the cells were 
mock-treated with DMSO (A) or the crosslinker DSP (B), lysed, and immunoprecipitated with anti-HA 
antibody. Bound material and 10% of input were subjected to SDS-PAGE and immunoblotting using 
anti-HA or anti-DYKDDDK antibody. The numerical values shown in the bottom panel of (B) are the 
relative band intensities of co-immunoprecipitated CDC50A when the band intensity in the mock lane 
is expressed as 1.0. 
 
Figure 3. Flippase activities across the lipid bilayer of the plasma membrane in HeLa cells stably 
expressing ATP10A 
(A–D) HeLa cells stably expressing HA-tagged P4-ATPase, as indicated, were established by infection 
with recombinant retrovirus and subsequent selection in the presence of G418. The cells were incubated 
with the indicated NBD-lipids at 15°C for the indicated times. After extraction with fatty acid–free BSA, 
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residual fluorescence intensity associated with cells was determined by flow cytometry. Fold increase 
in NBD-lipid uptake relative to that in vector-infected control cells (-) is shown. Graphs display 
averages from three independent experiments ± SD (*p < 0.05, **p < 0.01). (E–H) Parental HeLa cells 
([-], open squares) or cells stably expressing ATP10A were incubated with indicated NBD-lipids at 
15°C for the indicated times (x axis). Graphs are representative of two independent experiments, and 
results display averages from triplicates ± SD. (I) HeLa cells stably expressing HA-tagged P4-ATPase 
were lysed and subjected to SDS-PAGE and immunoblotting using anti-HA or anti--tubulin antibody 
to determine the total expression level of the P4-ATPase protein. (J) HeLa cells stably expressing HA-
tagged ATP10A or ATP10A(E203Q) were treated with a pool of siRNA for LacZ or ATP10A. After 
120 h, the cells were lysed and subjected to SDS-PAGE and immunoblotting using anti-HA or anti--
tubulin antibody. (K–N) Cells treated with a pool of siRNAs targeting LacZ or ATP10A were incubated 
with the indicated NBD-lipids at 15°C, as described in (A). Fold increase in NBD-lipid uptake relative 
to vector-infected control cells is shown. Graphs display averages from three independent 
experiments ± SD (*p < 0.05, **p < 0.01). 
 
Figure 4. Co-expression of ATP10A with CDC50A, but not CDC50B, increases flippase activities. 
HeLa cells were transiently transfected with an expression vector encoding HA-tagged ATP10A, 
ATP8B1, or ATP11A, either alone or together with a vector encoding FLAG-CDC50A or FLAG-
CDC50B. After 48 hr, cells were incubated with the indicated NBD-lipids at 15°C, and the residual 
fluorescence intensity associated with cells was determined by flow cytometry as described in the 
legend for Figure 3. Fold increase in NBD-lipid uptake relative to vector-transfected HeLa cells is 
shown. Graphs display averages from three independent experiments ± SD (*p < 0.05, **p < 0.01).  
 
Figure 5. Depletion of CDC50A abolishes the plasma membrane localization of P4-ATPases and 
their flippase activities. 
(A) HeLa cells stably expressing HA-tagged ATP10A, ATP10D, ATP8B1, or ATP11A were treated 
with a pool of siRNAs targeting LacZ or CDC50A. After 72 h, cells were fixed and processed for 
immunofluorescence analysis. For ER staining, the fixed and permeabilized cells were incubated with 
anti-HA and anti-calnexin antibodies, followed by Cy3-conjugated anti-rat and Alexa Fluor 488–
conjugated anti-mouse antibodies. For plasma membrane staining, cells were incubated with Alexa 
Fluor 488–conjugated anti-CD147 antibody prior to permeabilization, and with anti-HA antibody after 
permeabilization, as described in the legend for Figure 1D and F. Bar, 20 m. (BE) siRNA-treated 
cells were incubated with the indicated NBD-lipids at 15°C, and the residual fluorescence intensity 
associated with the cells was determined by flow cytometry as described in the legend for Figure 3. 
Fold increase in NBD-lipid uptake compared with vector-infected and siLacZ-treated control cells is 
shown. Graphs display averages from three independent experiments ± SD (*p < 0.05, **p < 0.01). (F) 
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siRNA-treated cells were lysed to isolate total RNAs, which were processed for RT-PCR.  
  
Figure 6. Overexpression of ATP10A causes a change in cell shape and a decrease in cell size. 
HeLa cells were transiently transfected with an empty expression vector (a) or an expression vector for 
FLAG-CDC50A (b), either alone or in combination with expression vector for ATP10A-HA (c) or 
ATP10A(E203Q)-HA (d). (A) After 48 h, the cells were incubated with anti-MHCI antibody prior to 
fixation to label the cells surface. After fixation and permeabilization, the cells were incubated with 
anti-HA and anti-FLAG followed by Cy3-conjugated anti-rat, Alexa Fluor 488-conjugated anti-mouse, 
and Alexa Fluor 647-conjugated anti-rabbit antibodies. Bars, 20 m. HeLa cells (a, cross marks) or cells 
expressing FLAG-CDC50A (b), or either ATP10A-HA (c) or ATP10A(E203Q)-HA (d) with FLAG-
CDC50A (asterisks) were outlined by setting a threshold for the fluorescence intensities of MHCI 
staining and each cell area was measured by ImageJ software, and the frequency distribution of cell size 
was shown in (B).  
 
Figure 7. Enhanced PC-flipping activity delays cell adhesion and spreading. 
(A and B) Adhesion assay was performed using HeLa cells stably expressing ATP10A-HA or 
ATP10A(E203Q)-HA. Cells were seeded onto a plastic dish and incubated for indicated times. After 
washing to remove non-adherent cells, adherent cells were fixed and stained with crystal violet. The 
stain was processed for measurement of absorbance at 570 nm. In (B), representative images of cells 
stained with crystal violet are shown. (CF) HeLa cells stably expressing ATP10A-HA or 
ATP10A(E203Q)-HA were processed for spreading assay. Cells were seeded onto FBS (C and D) or 
fibronectin (E and F)-coated coverslips and incubated for indicated times. After fixation and 
permeabilization, cells were incubated with anti-HA antibody followed by Cy3-conjugated anti-rat 
antibody and Alexa Fluor 488–conjugated phalloidin (C and E). Bars, 20 m. (D and F) Cell areas were 
measured by the MetaMorph software and the frequency distribution of cell areas at 180 min is shown. 
 
Figure 8. Sequence alignment of PC- and PS-flipping P4-ATPases. 
(A, B, and C) Upper and lower panels were shown PC- and PS-flipping P4-ATPases, respectively. 
Alignment of putative amino acid sequences of TM12 (A), TM3 (B), exoplasmic region between TM3 
and TM4TM4 (C), TM5-6 (D), TM7 (E), TM8-9 (F), TM10 (G). Bold blue letters are putative residues 
for PC-specificity and bold red letters are putative residues for PS-specificity (46). Bold underlined 
letters show the conserved residues with the blue or red amino acids. Bold light blue letters and bold 
pink letters represent residues conserved among mammalian PC-flippases and PS-flippases, 
respectively. exo, exoplasmic; cyto, cytoplasmic; P-domain, phosphorylation domain; N-domain, 
nucleotide-binding domain. 








